Tissues for transplantation

Logo
CSA Group
Standards Development Organisation:
Working Program:
Designation Number:
Z900.2.2
Standard Type:
National Standard of Canada - Domestic
Standard Development Activity:
Amendment Revision
ICS code(s):
11.020
11.100
Status:
Proceeding to development
SDO Comment Period Start Date:
SDO Comment Period End Date:
Posted On:

Scope:

Scope

1.1 Purpose

This Standard addresses issues related to the safety of human tissues used for transplantation. It includes quality system requirements and aspects of safety for potential and actual donors and recipients, personnel, and others who could be exposed to, or affected by, the transplant of tissues.

1.2 Inclusions

This Standard applies to establishments and individuals involved in the following activities related to tissues intended for transplantation:

a) processing;

b) evaluation of the safety of tissues prior to transplantation;

c) recordkeeping;

d) error, accident, and adverse reaction investigation;

e) distribution;

f) importation or exportation; and

g) complaints and recalls.

Notes:

1) Examples of establishments or individuals include the following:

a) tissue banks;

b) tissue processing facilities;

c) transplant programs and facilities (hospital and clinic);

d) tissue retrieval organizations; and

e) other tissue-dispensing services.

 

2) For guidance on autologous tissues, see AORN “Guideline for Autologous Tissue Management” in Guidelines for Perioperative Practice.

1.3 Limitations

This Standard is not intended to replace detailed specifications and SOPs but is intended to be used in their preparation.

1.4 Priority

This Standard contains particular requirements for tissues for transplantation and is intended to be used with CAN/CSA-Z900.1. Where differences exist, the requirements of this Standard apply.

Project need:

Project Need

To align Canadian requirements with those of the FDA (Food and Drug Administration) in the US, to ensure Canada can continue to import tissues for transplantation from the US once the FDA will have changed their requirements on this topic. This proposed Amendment is being developed at the request of Health Canada. It will provide the industry with requirements that are not in contradiction with the FDA so that importation of tissues for transplantation can continue.

Note: The information provided above was obtained by the Standards Council of Canada (SCC) and is provided as part of a centralized, transparent notification system for new standards development. The system allows SCC-accredited Standards Development Organizations (SDOs), and members of the public, to be informed of new work in Canadian standards development, and allows SCC-accredited SDOs to identify and resolve potential duplication of standards and effort.

Individual SDOs are responsible for the content and accuracy of the information presented here. The text is presented in the language in which it was provided to SCC.